Discloses a topical pharmaceutical composition comprising a cyclic depsipeptide of formula (II), a hydrophobic matrix and isopropyl myristate as a consistency agent. Also discloses use of the composition in the treatment of inflammatory and/or hyperproliferative and puritic skin diseases.